Compare AbCellera Biologics Inc (ABCL) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Vipshop Holdings Ltd - ADR — how do they compare? AbCellera Biologics Inc trades at $9.24 (market cap $2.85B), while Vipshop Holdings Ltd - ADR trades at $15.06 (market cap $7.40B). The key difference: Vipshop Holdings Ltd - ADR is far larger — about 2.6× AbCellera Biologics Inc's market cap, and Vipshop Holdings Ltd - ADR pays a 4.02% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | VIPS | |
|---|---|---|
Market Cap | $2.85B | $7.40B |
Sector | Health | Consumer Cyclical |
52-Week High | $9.76 | $20.68 |
52-Week Low | $2.78 | $12.92 |
Enterprise Value | $2.45B | $3.97B |
Dividend Yield | — | 4.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABCL's stock surged 6.13% to $6.93, driven by positive Phase 2 trial results for its menopause drug ABCL635, which showed an 83% reduction in hot flashes. Despite a bullish technical signal and strong analyst consensus (91.67% buy ratings), the company faces fundamental challenges with a net income margin of -248.84% and negative cash flow from operations. Revenue declined from $485M in 2022 to $75M in 2025, though recent news highlights potential from clinical advancements and a collaboration with Vertex.
The outlook is mixed: near-term optimism hinges on drug development success, but high valuation ratios (P/S of 31.63) and persistent losses pose risks. Investors should weigh the 54% upside to the $10.67 price target against cash burn and competitive pressures in biotech.
Vipshop Holdings (VIPS) trades at $15.68, up 1.75% with a bullish technical signal. The stock shows attractive valuation metrics including a P/E of 7.1 and P/S of 0.5, while maintaining solid profitability with 7.07% net margin and 18.43% ROE. Recent Q1 2026 earnings met expectations, and the company is pursuing growth through outlet store strategies. Analyst consensus leans bullish with 53.57% buy ratings.
The outlook remains constructive given discounted valuation and operational efficiency, though revenue stagnation and competitive pressures in China's e-commerce sector present challenges. Positive cash flow generation and strategic initiatives support potential upside, but investors should monitor execution on growth initiatives amid economic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
